Wildbaum G - Search Results

1

Coadministration of plasmid DNA constructs encoding an encephalitogenic determinant and IL-10 elicits regulatory T cell-mediated protective immunity in the central nervous system.

Schif-Zuck S, Wildbaum G, Karin N. Schif-Zuck S, et al. Among authors: wildbaum g. J Immunol. 2006 Dec 1;177(11):8241-7. doi: 10.4049/jimmunol.177.11.8241. J Immunol. 2006. PMID: 17114502

2

Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis.

Wildbaum G, Netzer N, Karin N. Wildbaum G, et al. J Immunol. 2002 Jun 1;168(11):5885-92. doi: 10.4049/jimmunol.168.11.5885. J Immunol. 2002. PMID: 12023393

3

Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis.

Salomon I, Netzer N, Wildbaum G, Schif-Zuck S, Maor G, Karin N. Salomon I, et al. Among authors: wildbaum g. J Immunol. 2002 Sep 1;169(5):2685-93. doi: 10.4049/jimmunol.169.5.2685. J Immunol. 2002. PMID: 12193742

4

Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading.

Wildbaum G, Netzer N, Karin N. Wildbaum G, et al. J Clin Invest. 2002 Sep;110(5):701-10. doi: 10.1172/JCI15176. J Clin Invest. 2002. PMID: 12208871 Free PMC article.

5

Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27.

Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Goldberg R, et al. Among authors: wildbaum g. J Immunol. 2004 Jul 15;173(2):1171-8. doi: 10.4049/jimmunol.173.2.1171. J Immunol. 2004. PMID: 15240707

6

Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27.

Goldberg R, Zohar Y, Wildbaum G, Geron Y, Maor G, Karin N. Goldberg R, et al. Among authors: wildbaum g. J Immunol. 2004 Nov 15;173(10):6465-71. doi: 10.4049/jimmunol.173.10.6465. J Immunol. 2004. PMID: 15528388

7

Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells.

Schif-Zuck S, Westermann J, Netzer N, Zohar Y, Meiron M, Wildbaum G, Karin N. Schif-Zuck S, et al. Among authors: wildbaum g. J Immunol. 2005 Apr 1;174(7):4307-15. doi: 10.4049/jimmunol.174.7.4307. J Immunol. 2005. PMID: 15778395

8

Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis.

Shehadeh N, Pollack S, Wildbaum G, Zohar Y, Shafat I, Makhoul R, Daod E, Hakim F, Perlman R, Karin N. Shehadeh N, et al. Among authors: wildbaum g. J Immunol. 2009 Jun 15;182(12):8104-9. doi: 10.4049/jimmunol.0803348. J Immunol. 2009. PMID: 19494336

9

A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2.

Izhak L, Wildbaum G, Zohar Y, Anunu R, Klapper L, Elkeles A, Seagal J, Yefenof E, Ayalon-Soffer M, Karin N. Izhak L, et al. Among authors: wildbaum g. J Immunol. 2009 Jul 1;183(1):732-9. doi: 10.4049/jimmunol.0802746. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535619

10

Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner.

Izhak L, Wildbaum G, Weinberg U, Shaked Y, Alami J, Dumont D, Friedman B, Stein A, Karin N. Izhak L, et al. Among authors: wildbaum g. J Immunol. 2010 Jan 15;184(2):1092-101. doi: 10.4049/jimmunol.0902725. Epub 2009 Dec 7. J Immunol. 2010. PMID: 19995900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters